LSRCY vs. NVO

Last updated Jun 25, 2026

LSRCY (Lasertec Corporation ADR) and NVO (Novo Nordisk A/S) are both stocks. LSRCY operates in Semiconductor Equipment & Materials (Technology), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, LSRCY returned 8.73%/yr vs 4.94%/yr for NVO. At a 0.14 correlation, their price movements are largely independent.

Performance

LSRCY vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lasertec Corporation ADR (LSRCY) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LSRCY achieves a 63.29% return, which is significantly higher than NVO's -3.56% return.

LSRCY

• 1D: -2.93%
• 1M: 29.27%
• YTD: 63.29%
• 6M: 62.13%
• 1Y: 139.57%
• 3Y*: 28.89%
• 5Y*: 8.73%
• 10Y*: —

NVO

• 1D: -0.02%
• 1M: 5.45%
• YTD: -3.56%
• 6M: -6.64%
• 1Y: -29.84%
• 3Y*: -13.64%
• 5Y*: 4.94%
• 10Y*: 8.62%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LSRCY vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
LSRCY Lasertec Corporation ADR	63.29%	101.43%	-63.70%	61.60%	-47.12%	155.72%	62.07%
NVO Novo Nordisk A/S	-3.56%	-39.22%	-15.93%	54.84%	22.66%	63.52%	6.12%

Correlation

The correlation between LSRCY and NVO is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.14
Correlation (All Time) Calculated using the full available price history since Sep 11, 2020	0.14

Fundamentals

Market Cap LSRCY : $27.79B NVO : $210.91B
EPS LSRCY : ¥199.39 NVO : DKK 27.42
PE Ratio LSRCY : 50.28 NVO : 11.36
PEG Ratio LSRCY : 1.08 NVO : 0.49
PS Ratio LSRCY : 17.69 NVO : 4.23
PB Ratio LSRCY : 19.84 NVO : 6.83
Total Revenue (TTM) LSRCY : ¥255.22B NVO : DKK 327.80B
Gross Profit (TTM) LSRCY : ¥152.65B NVO : DKK 268.30B
EBITDA (TTM) LSRCY : ¥130.18B NVO : DKK 181.54B

Return for Risk

LSRCY vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LSRCY

LSRCY Risk / Return Rank: 89
LSRCY Sharpe Ratio Rank: 91
LSRCY Sortino Ratio Rank: 89
LSRCY Omega Ratio Rank: 84
LSRCY Calmar Ratio Rank: 92
LSRCY Martin Ratio Rank: 89

NVO

NVO Risk / Return Rank: 20
NVO Sharpe Ratio Rank: 17
NVO Sortino Ratio Rank: 20
NVO Omega Ratio Rank: 19
NVO Calmar Ratio Rank: 21
NVO Martin Ratio Rank: 23

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LSRCY vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lasertec Corporation ADR (LSRCY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LSRCY	NVO	Difference
Sharpe ratio: Return per unit of total volatility	2.15	-0.58	+2.72
Sortino ratio: Return per unit of downside risk	2.86	-0.53	+3.39
Omega ratio: Gain probability vs. loss probability	1.33	0.92	+0.40
Calmar ratio: Return relative to maximum drawdown	4.68	-0.61	+5.29
Martin ratio: Return relative to average drawdown	10.18	-0.97	+11.15

LSRCY vs. NVO - Sharpe Ratio Comparison

The current LSRCY Sharpe Ratio is 2.15, which is higher than the NVO Sharpe Ratio of -0.58. The chart below compares the historical Sharpe Ratios of LSRCY and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LSRCY vs. NVO - Drawdown Comparison

The maximum LSRCY drawdown since its inception was -76.00%, roughly equal to the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for LSRCY and NVO.

Drawdown Indicators

	LSRCY	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-76.00%	-74.70%	-1.30%
Max Drawdown (1Y) Largest decline over 1 year	-29.99%	-49.17%	+19.18%
Max Drawdown (3Y) Largest decline over 3 years	-73.94%	-74.70%	+0.76%
Max Drawdown (5Y) Largest decline over 5 years	-76.00%	-74.70%	-1.30%
Max Drawdown (10Y) Largest decline over 10 years	—	-74.70%	—
Current Drawdown Current decline from peak	-13.73%	-65.55%	+51.82%
Average Drawdown Average peak-to-trough decline	-36.08%	-17.82%	-18.26%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.76%	30.93%	-17.17%

Volatility

LSRCY vs. NVO - Volatility Comparison

Lasertec Corporation ADR (LSRCY) has a higher volatility of 28.54% compared to Novo Nordisk A/S (NVO) at 12.00%. This indicates that LSRCY's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LSRCY	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.54%	12.00%	+16.54%
Volatility (6M) Calculated over the trailing 6-month period	48.40%	38.40%	+10.00%
Volatility (1Y) Calculated over the trailing 1-year period	66.92%	51.78%	+15.14%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	55.19%	38.48%	+16.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	55.10%	32.58%	+22.52%

Dividends

LSRCY vs. NVO - Dividend Comparison

LSRCY has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.80%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LSRCY Lasertec Corporation ADR	0.00%	0.00%	0.83%	0.00%	0.00%	0.22%	0.15%	0.00%	0.00%	0.00%	0.00%	0.00%
NVO Novo Nordisk A/S	3.80%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Financials

LSRCY vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Lasertec Corporation ADR and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

LSRCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lasertec Corporation ADR reported a gross profit of 23.35B and revenue of 42.04B. Therefore, the gross margin over that period was 55.5%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

LSRCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lasertec Corporation ADR reported an operating income of 15.48B and revenue of 42.04B, resulting in an operating margin of 36.8%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

LSRCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lasertec Corporation ADR reported a net income of 11.28B and revenue of 42.04B, resulting in a net margin of 26.8%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.

Frequently Asked Questions

Can I hold both LSRCY and NVO in my portfolio?

LSRCY and NVO have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LSRCY or NVO?

LSRCY has higher volatility (28.54%) compared to NVO (12.00%). In terms of maximum drawdown, LSRCY dropped -76.00% vs NVO's -74.70%.

Which has better risk-adjusted returns?

LSRCY currently has the higher Sharpe Ratio (2.15 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.